WEE1 and CHK1 Inhibitors: Exploiting Cell Cycle Checkpoints for Cancer Therapy
WEE1 and CHK1 inhibitors exploit cell cycle checkpoint defects in cancer. Synthetic lethality with p53 loss, mitotic catastrophe, and checkpoint control mechanisms.
Category Archives: Cell Death & DNA Repair
Autophagy Modulators: From Chloroquine to ULK1 Inhibitors – A Compound Selection Guide
Discover autophagy research compounds including chloroquine, bafilomycin A1, 3-MA, ULK1 inhibitors, and rapamycin – a complete guide to early and late-stage autophagy modulators for research.
Necroptosis Research Compounds: RIPK1, RIPK3, and MLKL Inhibitors Explained
Explore necroptosis inhibitors targeting the RIPK1-RIPK3-MLKL axis, from pioneering necrostatin-1 to GSK872 and necrosulfonamide, essential tools for inflammation and neurodegeneration research.
Pyroptosis and Inflammasome Research: NLRP3 Inhibitors and Gasdermin Biology
Examine NLRP3 inflammasome inhibitors like MCC950, gasdermin cleavage mechanisms, and pyroptotic cell death in inflammatory diseases from CAPS to Alzheimer’s disease research.
PARP Inhibitors: Mechanism, Research Compounds, and Synthetic Lethality Applications
Explore PARP inhibitor mechanisms, synthetic lethality with BRCA mutations, FDA-approved drugs, and research compounds for DNA damage and cancer studies.
Bcl-2 Family Inhibitors: Venetoclax, Navitoclax, and Tools for Apoptosis Research
Explore Bcl-2 family inhibitors for apoptosis research: venetoclax selectivity, navitoclax broad inhibition, and emerging Mcl-1 approaches. Understanding BH3 mimetics and cellular dependencies.
Ferroptosis Inducers and Inhibitors: Research Compounds for Iron-Dependent Cell Death
Comprehensive guide to ferroptosis research compounds: erastin and RSL3 inducers, GPX4 inhibitors, ferrostatin-1 and liproxstatin-1 rescue controls. Includes experimental design framework for iron-dependent cell death studies.
